Summary
This 8-K filing from Axon Enterprise, Inc. (AXON), dated August 8, 2023, announces the release of the company's second quarter 2023 financial results via a shareholder letter. While the 8-K itself is brief, it directs investors to Exhibit 99.1 for detailed financial performance, including statements of operations, segment reporting, balance sheets, cash flow information, statistical measures, and reconciliations of GAAP to non-GAAP financial measures. Investors should consult this attached exhibit for a comprehensive understanding of Axon's performance during the second quarter.
Key Highlights
- 1Axon Enterprise, Inc. announced its second quarter 2023 financial results on August 8, 2023.
- 2The results were communicated through a shareholder letter, which is attached as Exhibit 99.1.
- 3The filing includes unaudited condensed consolidated statements of operations, segment reporting, balance sheets, and cash flow information.
- 4Reconciliations of GAAP to non-GAAP financial measures are provided, offering insights into the company's operational performance beyond standard accounting.
- 5Key statistical measures for the quarter are also included in the attached exhibit.
- 6The Chief Operating Officer and Chief Financial Officer signed the report, indicating executive review of the disclosed information.
Frequently Asked Questions
The detailed financial results, including statements of operations, balance sheets, cash flow, segment reporting, statistical measures, and GAAP to non-GAAP reconciliations, are provided in Exhibit 99.1 attached to this 8-K filing.
Non-GAAP financial measures are provided to offer investors a clearer view of Axon's underlying operational performance by excluding certain items that may not be indicative of ongoing business trends. These are important for a more nuanced understanding of profitability and financial health.
No, this 8-K filing primarily serves as a notification that Axon has released its second quarter 2023 financial results. The substantive financial details are contained within the attached Exhibit 99.1, which is the shareholder letter and accompanying financial statements.